The regulation of mRNA stability plays an important role in the control of gene expression during cell motility and invasion. We previously reported that GTPase-activating protein [Src homology 3 (SH3) domain] binding protein (G3BP), a marker of cytoplasmic stress granules that are formed in stressed cells and regulate mRNA stability, binds and degrades the mRNA of binder of Arl two (BART) that inhibits retroperitoneal invasion and hepatic metastasis of pancreatic cancer cells. Here, we report that overexpression of the amino (N)-terminal region of G3BP, including the binding region for BART mRNA, dominant-negatively inhibits formation of the complex between endogenous G3BP and BART mRNA, and increases the expression of BART. This, in turn, inhibits the invasiveness of pancreatic cancer cells. On the other hand, the carboxy (C)-terminal region of G3BP is associated with phosphorylation of eukaryotic translation initiation factor 2a (eIF2a) that initiates stress granule assembly but does not modulate the posttranscriptional regulation of BART mRNA. N-terminal G3BP also plays a role in regulating secreted matrix metalloproteinases, transcription factors, and a variety of genes involved in cell adhesion and motility. These results suggest that N-terminal G3BP contributes to posttranscriptional regulation of cell motility and invasive capacity of pancreatic cancer. Mol Cancer Res; 9(7); 856-66. Ó2011 AACR.
Introduction
G3BP was originally identified on the basis of its ability to bind the Src homology 3 (SH3) domain of Ras GTPaseactivating protein p120 (RasGAP), which functions as a physiologic negative regulator of Ras signaling in exponentially growing cells (1) (2) (3) . The phosphorylation of G3BP and its association with RasGAP are affected by extracellular stimuli (3); however, functional consequences of the binding of G3BP to RasGAP have not been fully elucidated. The N-terminus of G3BP is a nuclear transport factor-2 (NTF-2)-like domain homologous to NTF-2 and is followed by acidic and proline-rich regions, an RNA-binding domain with an RNA recognition motif (RRM), and multiple arginine-glycine rich (RGG) motifs (1) . The NTF-2-like domain of G3BP influences the cellular localization of proteins and its oligomerization with itself or with other partners (4) . Indeed, in vitro binding assays suggest that the NTF-2-like domain of G3BP is responsible for RasGAP binding (5) . Assembly of stress granules (SG) can be dominantly induced by G3BP overexpression (4) . G3BP binds to Caprin-1 through the NTF-2-like domain, and this complex is localized in cytoplasmic granules that contain a major part of the cytoplasmic RNA (6) . This complex induces the formation of cytoplasmic SGs that form in response to a variety of cellular stresses (6) . SGs contain mRNAs, certain translation-initiating factors, and RNAbinding proteins that can be directed to either translation initiation or decay pathways (4) . G3BP is likely to regulate the transport and translation of mRNAs of proteins involved in cellular proliferation and migration in multiple cell types (6) . This suggests that the NTF-2-like domain of G3BP influences gene expression by affecting the steadystate levels of mRNA following posttranscriptional repression or induction through binding to partner proteins and SG formation.
Another interesting feature of G3BP is that the RRM domain mediates the binding of G3BP to specific RNA sequences so that G3BP can exert its function as a dinucleotide-specific single-strand-specific endoribonuclease (7) . G3BP can bind to the 3 0 untranslated region (3 0 UTR) of human c-Myc mRNA through the RRM domain in a phosphorylation-dependent manner to increase its degradation in vitro (3). It is the only known endoribonuclease that requires site-specific phosphorylation for its catalytic activity (3) . A small number of general pathways seem to be responsible for degrading most mRNAs; therefore, regulatory mechanisms are thought to target the initial events that direct the mRNA into one of these pathways, to either maintain it in a translationally inactive state, or permit its translation (8) . The major decay-initiating events are deadenylation, endonucleolytic cleavage, and decapping (9) . cMyc transcript levels, which are considered to be regulated by G3BP, are subject to posttranscriptional regulation by a sequential pathway involving deadenylation followed by degradation of the mRNA body (10) . In contrast, G3BP can stabilize tau mRNA, a microtubule-associated protein highly regulated during neuronal cell differentiation (11) . In addition to endoribonuclease activity, G3BP functions to stabilize mRNA. The studies that examine the intersection of G3BP with RNA metabolism have proposed that the RRM domain of G3BP plays an important role in regulating mRNA translation or decay, or both.
We previously reported that binder of Arl two (BART) inhibits retroperitoneal invasion and liver metastasis of pancreatic ductal adenocarcinoma (PDAC) cells in an orthotopic xenograft model (12) . Our findings provide an explanation for the oncogenic function of G3BP to induce tumor invasion and metastasis by mediating BART mRNA decay. Here, we provide evidence that the Nterminal G3BP (G3BP ) functions in the posttranscriptional regulation of BART mRNA for the promotion of cell motility and invasion in PDAC. The C-terminal G3BP (G3BP 241-466 ) functions in SG assembly, but the expression of BART and c-Myc mRNA is not regulated. Moreover, G3BP plays a critical role in establishing a pattern of gene expression that favors PDAC cell motility and invasive behavior.
Materials and Methods

Identification of the BART-binding region in G3BP
We produced 6 deletion constructs of G3BP (G3BP 1-420 , G3BP , G3BP 1-240 , G3BP 1-180 , G3BP , and G3BP 1-80 of accession number NM_005745) by cloning the pcDNA3.1(þ)/Myc-HisA vector (Invitrogen) into appropriate sites. COS7 cells were transiently transfected with each plasmid by using FuGENE6 (Roche). After 48 hours of transfection, cell extracts were immunoprecipitated with agarose-conjugated anti-Myc antibody. Each Myctagged immunoprecipitate was incubated with biotinylated BART 3 0 UTR (748-1703 of accession number NM_012106) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) RNA immobilized on streptavidin magnetic beads for 2 hours at 4 C. Bound proteins in the pull-down material were washed using strong permanent magnets (MPC-S; Dynal) and analyzed by Western blotting using anti-Myc antibody.
Real-time quantitative reverse transcriptase-PCR
Total RNA was extracted using the RNeasy kit with DNase I treatment, and reverse transcribed as described earlier. The resultant cDNA was amplified by real-time PCRusing assays-on-demand primers and TaqMan probes for BART (Hs00183708_m1), c-Myc (Hs00153408_m1), and GAPDH (Hs99999905_m1; Applied Biosystems). Each sample was run in triplicate for both BART and GAPDH in a 20-mL reaction solution, using TaqMan Universal PCR Master Mix according to the manufacturer's instructions (Applied Biosystems). The gene-specific reverse transcriptase-PCR (RT-PCR) products were measured continuously on an ABI PRISM 7000 Sequence Detection system (Applied Biosystems). Transcript levels of BART and c-Myc were normalized to GAPDH in each sample by using the standard curve method as described by the manufacturer.
Matrigel invasion assay
The 2-chamber invasion assay (24-well plates, 8-mm pore size, membrane coated with a layer of Matrigel extracellular matrix (ECM) proteins; Becton Dickinson) was used to assess cell invasion. A total of 5.0 Â 104 cells were seeded in serum-free medium into the top chamber and allowed to invade toward 5% fetal calf serum (FCS) as a chemoattractant in the bottom chamber. After 20 hours of incubation, the number of invading cells at the bottom of the membrane was estimated by counting 3 independent visual fields in a microscope.
Results
Overexpression of G3BP in PDAC
G3BP expression in cell lysates from PDAC cell lines and from a line of immortalized normal pancreatic nestinexpressing epithelial (HPNE) cells (13) was determined by Western blot analysis (Fig. 1A) . All PDAC cell lines showed high levels of G3BP expression compared with HPNE cells. G3BP expression in PDAC and in normal tissue sections was also investigated using an anti-G3BP monoclonal antibody (Fig. 1B-E ). In concordance with the results of the Western blotting, immunohistochemical analysis revealed strong signals of G3BP in the cytoplasm of cancer cells, but its expression was hardly detectable in normal pancreatic tissues. Among the 5 PDACs examined by immunohistochemistry, all specimens showed strong signals of G3BP. These observations suggest that G3BP is overexpressed in PDAC compared with normal pancreas.
The acidic domain of G3BP is essential for binding to BART mRNA G3BP binds to the 3 0 UTR of BART (748-1703 of accession number NM_012106) and degrades BART mRNA (12) . To define the region of G3BP that is required for its binding to BART-3 0 UTR, the binding ability of 6 Myc-tagged fragments of G3BP ( Fig. 2A ; 1-420, 1-330, 1-240, 1-180, 1-135, and 1-80) to BART-3 0 UTR were investigated. Each fragment was transiently expressed in COS7 cells and high levels of expression were confirmed by Western blotting (Fig. 2B) . Myc-tagged proteins in total cell lysates were immunoprecipitated with anti-Myc antibody and incubated with in vitro-transcribed biotinylated BART-3 0 UTR or control GAPDH RNA immobilized on streptavidin magnetic beads. The immunoprecipitated complexes were then pulled down with magnets. G3BP 1-420 , G3BP , G3BP , and G3BP 1-180 could interact with BART-3 0 UTR, but G3BP 1-135 and G3BP could not interact (Fig. 2C) . GAPDH mRNA failed to pull down the G3BP fragments (data not shown). These experiments suggest that the region spanning amino acid residues 136 to 180, located in the acidic domain, is sufficient for binding BART-3 0 UTR.
Inhibition of G3BP endoribonuclease activity for BART-3 0 UTR transcript by synthesized polypeptides of G3BP To investigate the functional significance of the G3BP 136-180 fragment that includes the region that binds to the BART-3 0 UTR transcript, we used synthetic 45-amino acid polypeptides (G3BP 136-180 peptide). BART-3 0 UTR was incubated with recombinant G3BP with or without the G3BP 136-180 peptide, followed by pull-down of the BART transcript. When the G3BP 136-180 peptide was added, it was able to inhibit formation of the complex between recombinant G3BP and BART-3 0 UTR (Fig. 2D ), thus indicating that this synthesized peptide functions in a dominant-negative manner. To determine dominant-negative effects of the G3BP 36-180 peptide on the RNase activity of G3BP, we conducted an in vitro mRNA decay assay (Fig. 2E) . In vitro-transcribed BART-3 0 UTR was efficiently cleaved after 30 minutes of incubation with recombinant G3BP in the absence of G3BP 136-180 peptide, but mRNAs for GAPDH were not cleaved. G3BP 136-180 peptide treatment strongly decreased cleavage of the BART-3 0 UTR by G3BP but had no effect on control GAPDH. These results suggest that the interaction of G3BP and BART-3 0 UTR is mediated through the region of G3BP and that G3BP 136-180 is necessary for specific G3BP RNase activity on BART mRNA.
Exogenous overexpression of N-terminal G3BP dominant-negatively increases BART expression in PDAC cells
To examine the global function of G3BP 136-180 on posttranscriptional regulation, we established PANC-1 derivative clones from a PDAC cell line. These clones constitutively expressed either exogenous N-terminal G3BP (G3BP-N, 1-180) with the NTF-2-like domain and G3BP , or the C-terminal G3BP (G3BP-C, 241-466), including the RNA-binding domains (Fig. 3A) . Western blot analysis shows the expression levels of the exogenous G3BP fragments compared with mock-control clones (Fig. 3B ).
BART and c-Myc mRNAs are specifically associated with G3BP in PDAC cells (12) . This was confirmed by immunoprecipitation (IP) experiments in PANC-1 cells by using anti-G3BP or control mouse IgG monoclonal antibodies (Fig. 3C ). The immunoprecipitated transcripts were then converted to cDNA by reverse transcription, and RT-PCR was conducted. We found that antibodies to G3BP specifically immunoprecipitated both BART and c-Myc mRNAs. Nontarget GAPDH mRNA was also amplified, albeit inefficiently, and to the same extent in both IP groups. These findings reveal the presence of low levels of contaminating, nonspecific mRNA in all IP samples, yet verifies that equal amounts of input material was used, and shows that the G3BP-IP materials were enriched compared with the control IgG-IPs. Following this, quantitative RT-PCR analysis was conducted to identify the levels of BART mRNA in the G3BP deletion mutant clones and to thereby determine the functions of N-terminal G3BP on the posttranscriptional regulation of BART. We found that BART mRNA was upregulated in N-terminal G3BP PANC-1 clones but not in mock or C-terminal clones by real-time quantitative RT-PCR (Fig. 3D ). The same result was observed by Western blotting (Fig. 3E) . Interestingly, G3BP-N cells also increased c-Myc mRNA as compared with mock-control clones; however, G3BP-C failed to alter (Fig. 3F) . These results indicate that G3BP-N functions in a dominant-negative manner by stabilizing BART mRNA and that G3BP-N also affects the mRNA levels of c-Myc that binds to the C-terminal RNA-binding domain of G3BP.
Exogenously overexpressed N-and C-terminal G3BPs colocalize with cytoplasmic RNA in PDAC cells
To show the mechanism of overexpressed G3BP-N in regulating the target transcripts via inhibition of endogenous G3BP activity, we investigated the subcellular colocalization 0 UTR with Myc-tagged G3BP was assessed by pull-down of the RNA using streptavidin-conjugated beads, followed by Western blotting with anti-Myc antibody. D, reduction of the complex formed between recombinant G3BP and biotinylated BART-3 0 UTR transcript by treatment with G3BP 136-180 peptides. E, BART 3 0 UTR or control GAPDH RNA was incubated with recombinant G3BP with or without pretreatment with G3BP 136-180 peptides. The RNA was electrophoresed and visualized by SYBR Gold staining. Closed arrowhead, BART-3 0 UTR; arrow, control GAPDH.
of Myc-tagged N-and C-terminal G3BPs, and total cellular RNA in G3BP-N and G3BP-C PANC-1 cells. Ethidium bromide staining of total cellular RNA showed that the bulk of cytoplasmic RNA colocalized with the transfected Myctagged N-and C-terminal G3BP (Fig. 4A ). In addition, RNase treatment eliminated all ethidium bromide staining in the cytoplasm (Supplementary Fig. S1 ). These results suggest that not only G3BP-C, including the RRM and RGG domains, but also G3BP-N binds to RNA. Importantly, G3BP-N was diffusely distributed in the cytoplasm, whereas the C-terminal form was recruited to the cytoplasmic ribonucleoprotein (RNP) granules (Fig. 4A) . In line Figure 4 . Overexpressed C-terminal G3BP is localized in cytoplasmic SGs in PDAC cells. A, immunocytochemical staining of exogenous Myc-tagged G3BP fragments and total cellular RNA in PANC-1 transfectants, as determined using anti-Myc antibody (green) and ethidium bromide (red), respectively, and 4 0 ,6-diamidino-2-phenylindole (DAPI) staining (blue, nucleus). Bars, 10 mm. B, stable G3BP-N and G3BP-C cells of PANC-1 were exposed to 500 mmol/L SA for 30 minutes. Immunocytochemical staining, as determined with anti-Myc antibody (green), anti-TIA-1 antibody (violet), and DAPI staining (blue). White arrows and arrowheads indicate Myc-tagged G3BP-C colocalizing with endogenous TIA-1 in SGs after treatment with or without SA, respectively. Yellow arrows indicate SGs in which TIA-1 is localized. Bars, 10 mm. C, confocal Z stack with white boxes (a and b in B) depicting the position where SGs associate with Myc-tagged G3BP-C and endogenous TIA-1, as determined with anti-Myc antibody (green), anti-TIA-1 antibody (violet), and DAPI staining (blue). Arrows and arrowheads indicate Myc-tagged G3BP-C colocalizing with endogenous TIA-1 in SGs after treatment with or without SA, respectively. their ability to bind RNA is reportedly sufficient to concentrate them in SGs (4). To verify that the C-terminal form is present in SGs, cells were immunostained under conditions of oxidative stress caused by treatment with SA (Fig. 4B) . In G3BP-C cells, the C-terminal form colocalized in SGs with the endogenous SG-specific protein TIA-1, with or without SA treatment (white arrows and arrowheads in Fig. 4B ). This colocalization was confirmed in the confocal Z stack (Fig. 4C) . Thus, RNP granules induced by the overexpression of G3BP-C might consist of SGs. TIA-1 was localized at SA-induced cytoplasmic granules in G3BP-N cells (yellow arrows in Fig. 4B ). However, SA did not induce colocalization of transfected G3BP-N with endogenous TIA-1 at SGs in G3BP-N cells (Fig. 4B) . These results suggest that exogenously overexpressed G3BP-N is not associated with SG formation and does not inhibit SAinduced stress granule formation.
Exogenous overexpression of C-terminal G3BP induces eIF2a phosphorylation
SG assembly is usually initiated by the phosphorylation of eukaryotic translation initiation factor 2a (eIF2a), a translational initiation factor that exists as a component of the eIF2-GTP-tRNAMet ternary complex (15) . To further analyze whether overexpressed G3BP-N and G3BP-C function in SG formation, we investigated the phosphorylation of eIF2a in stable transfectants by immunoblotting (Fig. 5A) . Overexpression of N-terminal G3BP did not induce phosphorylation of eIF2a; however, C-terminal G3BP did induce eIF2a phosphorylation. Subsequently, we decided to test the capacity of endogenous G3BP to bind to exogenously overexpressed N-or C-terminal G3BP. When SG formation is initiated, endogenous G3BP forms multimers (16) . Extracts prepared from mock-control, G3BP-N, and G3BP-C PANC-1 cells were subjected to IP with anti-Myc or anti-G3BP antibodies (Fig. 5B) . Endogenous G3BP was efficiently coimmunoprecipitated with the Myc-tagged C-terminus G3BP but not with the Myctagged N-terminus G3BP. Combined with the result of Figure 4B , these data suggest that overexpressed N-terminal G3BP did not induce self-association of G3BP and subsequent SG assembly; however, it did increase BART mRNA in a dominant-negative manner ( Fig. 3D and E) . As reported previously (4), the C-terminus G3BP plays a role in inducing SG formation; however, it is not associated with the posttranscriptional regulation of BART or c-Myc mRNAs (Fig. 3D-F ).
Exogenous overexpression of N-terminal G3BP inhibits cell motility and invasion in PDAC
To investigate the functional significance of N-and Cterminal G3BP for cell motility and invasion in PDAC, we employed in vitro tumor culture assays. G3BP-C PANC-1 cells appeared more spindle-shaped and showed a mesenchymal morphology as compared with mock-control and G3BP-N cells, both of which showed epithelial cell morphology (Fig. 6A) . We next measured directed motility into an artificial wound, using a confluent monolayer culture of G3BP-N or G3BP-C PANC-1 clones, and compared them with mock-control cells (Fig. 6B and C) . G3BP-N cells showed inhibition of motility activity into the wound area as compared with mock and C-terminal PANC-1 cells. Despite the spindle-shaped morphologic change of the G3BP-C cells, no other significant changes were seen. To verify these results, a motility assay on uncoated membranes was conducted to quantify motile cells. Figure 6D showed that G3BP-N PANC-1 cells were significantly less motile than the mock-control or G3BP-C cells. In addition, in 2-chamber invasion assays, G3BP-N clones were significantly less invasive than the mock-control or G3BP-C cells (Fig. 6E) . To rule out bias due to differences in proliferation, we conducted MTT assays and the results showed that N-and C-terminal G3BP clones did not affect cell proliferation ( Supplementary  Fig. S2 ). These results suggest that the dominant-negative expression of Myc-tagged N-terminal G3BP decreases cellular motility and invasiveness of PDAC cells. Thus, in contrast to the C-terminus G3BP, the N-terminus G3BP seems to accelerate cellular motility and invasiveness.
Transcriptional effects of N-terminal G3BP in PDAC
To determine the transcriptional program and pathways regulated by the expression of exogenous G3BP-N, which might underlie the differences in cell motility and invasion, we conducted cDNA microarray gene expression profiling experiments with 3 G3BP-N PANC-1 clones and 3 mockcontrol PANC-1 clones (Tables 1 and 2 ). Raw data from the microarray experiments were uploaded onto the Gene Expression Omnibus Database (http:\\www.ncbi.nlm.nih. gov\geo\ GEO accession: GSE23342). Enrichment was defined as genes exhibiting a 2-fold increase in the average ratio in signal intensity. Five genes among the 14 upregulated genes were related to cell adhesion, motility, and invasion. Many of these genes have been previously described as modulators of cell invasion in various tumor cell models.
The group of downregulated genes consists mainly of genes associated with cell motility and invasion. We confirmed our microarray data of the vast majority of genes tested at the RNA level by RT-PCR analysis (Supplementary Fig. S3 ). Our microarray results suggest that N-terminal G3BP predominantly contributes to the regulation of genes involved in cell motility, invasion, and adhesion in PDAC. Columns, mean; bars, SD. *, P < 0.005; **, P < 0.004 compared with mock-control and G3BP-C cells, respectively. D, Transwell motility assay in control, G3BP-N, and G3BP-C cells. Migrated cells in 4 fields per group were counted. Data are representative of 3 independent experiments. Columns, mean; bars, SD. *, P < 0.005; **, P < 0.002 compared with mock-control cells. E, quantification of the 2-chamber invasion assay with PANC-1 control, G3BP-N, and G3BP-C cells. Invaded cells in 4 fields per group were counted. Data are representative of 3 independent experiments. Columns, mean; bars, SD. *, P < 0.002 compared with mock-control cells.
Discussion
We previously reported that G3BP plays a role in inducing invasion and metastasis of PDAC cells by BART mRNA decay (12) . BART was originally identified as a binding partner of ARL2 (17), a small G-protein implicated in the regulation of microtubule dynamics or folding (18) . To investigate the mechanisms by which G3BP modulates cell motility and invasion in PDAC cells, we overexpressed Nterminal G3BP and C-terminal G3BP . We found that overexpressed G3BP-N, which contains the NTF-2-like domain and G3BP 136-180 , dominant-negatively increases BART expression and thereby inhibits cell motility and invasion of PDAC cells. Thus, it is likely that the N-terminal domain of endogenous G3BP enhances the invasive ability of PDAC cells by posttranscriptionally regulating the level of specific transcripts. The association of a particular mRNA with G3BP may be highly regulated and might depend on interaction with other proteins (3, 6, 19) . The interaction of G3BP with cyclin-dependent kinase 7 (CDK7) mRNA is dependent on the interaction of RasGAP with Filamin C (FLN-C; ref. 19) . When RNA interference (RNAi) interrupts the interaction between RasGAP and FLN-C, CDK7 mRNA is released from G3BP (19) . We also reported that intracellular CD24 binds to G3BP and inhibits G3BP RNase activity in PDAC cells (12) . Thus, binding proteins of G3BP may form a link between G3BP and the mRNAs and influence cellular mRNA stabilization and protein synthesis. In addition, the NTF-2-like domain plays an important role both in recruiting G3BP to the vicinity of local mRNA concentrations and in facilitating its interaction with selected mRNA species. Our results suggest that a fragment of the NTF-2-like domain as well as a minimum binding region of the acidic domain of G3BP could contribute to the recruitment of G3BP to BART mRNA for subsequent BART mRNA degradation.
In mammalian cells, phosphorylation of eIF2a can trigger the assembly of SGs and the self-aggregation of G3BP (15) . In the present study, exogenously overexpressed C-terminal G3BP could upregulate the phosphorylation of eIF2a and induced SG assembly. Despite the colocalization of overexpressed G3BP-C fragments with RNA observed by immunostaining of G3BP-C cells (Fig. 4A) , no significant changes in the mRNA expression of BART or c-Myc were detected (Fig. 3D-F) . SGs may be sites of mRNA sorting whereby the structure and composition of individual mRNPs might determine whether mRNAs are repacked into translationally competent mRNPs or degraded (14) . G3BP has been shown to bind c-Myc (3) and tau mRNA (11), inducing degradation through endoribonuclease activity and stabilization, respectively. Thus, the C-terminal G3BP may not always function in mRNA degradation in SGs, but it may instead be sometimes associated with mRNA stabilization. SG assembly can be dominantly induced by full-length G3BP overexpression (4). Moreover, G3BP binds to Caprin-1 through the NTF-2-like domain and this complex induces the formation of cytoplasmic SGs (6) . In addition, G3BP 1-141 containing the NTF-2-like domain is recruited to SGs in COS cells (4) . In the present study, G3BP containing the NTF-2-like domain and the BART mRNA-binding region did not induce G3BP selfassociation in PDAC cells. Because G3BP self-association is required for SG formation, it is likely that the N-terminal G3BP does not play a role in SG formation in PDAC cells. Nevertheless, G3BP 1-180 is essential for degrading specific mRNAs, because exogenously overexpressed G3BP 1-180 dominant-negatively increased the expression of mRNAs for BART and c-Myc. We conclude that G3BP 1-180 is involved in mRNA degradation in PDAC cells, although the exact mechanism by which it modulates mRNA degradation remains to be clarified. In this respect, further studies are needed to show the mechanism by which G3BP binds and recruits BART mRNA to SGs.
To identify the factors and pathways regulated by Nterminal G3BP and to obtain leads into the mechanisms behind the inhibition of cell invasion by dominant-negatively overexpressed N-terminal G3BP, we conducted global expression analyses (Tables 1 and 2 ). Fourteen genes were upregulated (Table 1 ) and 6 genes were downregulated (Table 2) after N-terminal G3BP was overexpressed in PANC-1 cells. Strikingly, 5 of the upregulated transcripts coded for proteins involved in cellular adhesion and/or invasion. Of these, CLU, a secreted glycoprotein with stress-induced expression in various diseased and aged tissues, decreases cell proliferation and metastatic behavior of prostate cancer cells (20) . AHR participates in signaling pathways regulating cell-cell and cell-substratum adhesion (21) . HPX and hemopexin domains of human proteins fulfill functions in the activation of matrix metalloproteinase (MMP), the inhibition of MMPs, dimerization, binding of substrates or ligands, cleavage of substrates, and endocytosis (22) . NSEP1, a member of the Y-box binding factor family of evolutionarily conserved DNA/RNA-binding factors, decreases collagen type I mRNA and protein levels (23) . PAI-1, a member of the serine protease inhibitor (serpins) family that blocks the activity of urokinase-type plasminogen activator (uPA), is downregulated in PDAC (24) and decreases tumor invasiveness and metastatic potential in cell lines derived from colon cancer, fibrosarcoma (25) , and murine melanoma (26) . Concerning the downregulated genes, 4 of the identified transcripts code for proteins involved in cellular adhesion and/or invasion. These include MFGE8 identified as a marker of breast cancer (27) with angiogenesis-promoting activity (28) and anticoagulant activity (29) . HSPG2 is a major component of blood vessel basement membranes and positively regulates angiogenesis (30) . Interestingly, APOE induces expression of HSPG2 (31) .
LGALS1 increases motility of glioma cells and the reorganization of the actin cytoskeleton associated with increased expression of RhoA, a protein that modulates actin polymerization and depolymerization (32) . Accordingly, the N-terminal region of G3BP could play a role in regulating secreted MMPs, transcription factors, and a variety of genes involved in cell adhesion and motility, which, in turn, would enhance cell motility and invasion capacity of PDAC cells. Future studies are essential to determine the endoribonuclease activity of G3BP toward specific mRNAs identified in this cDNA microarray analysis. Furthermore, the invasive activity of these genes in PDAC cells should be determined by the use of RNAi knockdown techniques.
The data presented here show that G3BP 1-180 containing the novel RNA-binding residue G3BP 136-180 contributes to posttranscriptional regulation of specific mRNAs for the promotion of cell motility and invasion in PDAC. Moreover, the N-terminus of G3BP plays a critical role in establishing a pattern of gene expression that favors PDAC cell motility and invasive behavior. Thus, G3BP , especially G3BP 136-180 , could represent a novel target for blocking tumor invasion and metastasis in PDAC.
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